» Articles » PMID: 18992407

Emerging Infections: a Perpetual Challenge

Overview
Date 2008 Nov 11
PMID 18992407
Citations 93
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging and re-emerging infectious diseases, and their determinants, have recently attracted substantial scientific and popular attention. HIV/AIDS, severe acute respiratory syndrome, H5N1 avian influenza, and many other emerging diseases have either proved fatal or caused international alarm. Common and interactive co-determinants of disease emergence, including population growth, travel, and environmental disruption, have been increasingly documented and studied. Are emerging infections a new phenomenon related to modern life, or do more basic determinants, transcending time, place, and human progress, govern disease generation? By examining a number of historically notable epidemics, we suggest that emerging diseases, similar in their novelty, impact, and elicitation of control responses, have occurred throughout recorded history. Fundamental determinants, typically acting in concert, seem to underlie their emergence, and infections such as these are likely to continue to remain challenges to human survival.

Citing Articles

Integrated One Health strategies in Dengue.

Procopio A, Colletta S, Laratta E, Mellace M, Tilocca B, Ceniti C One Health. 2024; 18:100684.

PMID: 39010969 PMC: 11247296. DOI: 10.1016/j.onehlt.2024.100684.


In vitro antibacterial activity of Bersama abyssinica Fresen crude extract against representative Gram-positive and Gram-negative bacterial isolates.

Mossie T Vet Med Sci. 2024; 10(4):e1498.

PMID: 38896065 PMC: 11186053. DOI: 10.1002/vms3.1498.


Concealing Disease: Trade and Travel Barriers and the Timeliness of Outbreak Reporting.

Worsnop C Int Stud Perspect. 2024; 20(4):344-372.

PMID: 38626279 PMC: 7149472. DOI: 10.1093/isp/ekz005.


Domestic politics and the WHO's International Health Regulations: Explaining the use of trade and travel barriers during disease outbreaks.

Worsnop C Rev Int Organ. 2024; 12(3):365-395.

PMID: 38624276 PMC: 7149042. DOI: 10.1007/s11558-016-9260-1.


SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.

Pham T, Huynh T, Choi J, Lee J, Park S, Kim B J Virol. 2023; 97(12):e0173723.

PMID: 38051260 PMC: 10734463. DOI: 10.1128/jvi.01737-23.


References
1.
Meselson M, Guillemin J, Hugh-Jones M, Langmuir A, Popova I, Shelokov A . The Sverdlovsk anthrax outbreak of 1979. Science. 1994; 266(5188):1202-8. DOI: 10.1126/science.7973702. View

2.
Morens D, Folkers G, Fauci A . The challenge of emerging and re-emerging infectious diseases. Nature. 2004; 430(6996):242-9. PMC: 7094993. DOI: 10.1038/nature02759. View

3.
Taubenberger J, Hultin J, Morens D . Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir Ther. 2007; 12(4 Pt B):581-91. PMC: 2391305. View

4.
Novembre J, Galvani A, Slatkin M . The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol. 2005; 3(11):e339. PMC: 1255740. DOI: 10.1371/journal.pbio.0030339. View

5.
Cheng K, Leung P . What happened in China during the 1918 influenza pandemic?. Int J Infect Dis. 2007; 11(4):360-4. DOI: 10.1016/j.ijid.2006.07.009. View